Cellular Pathology
A section of Cells (ISSN 2073-4409).
Section Information
The Cellular Pathology section will focus on cellular pathology, molecular mechanisms of diseases, and characterization of cellular pathways relevant to pathogenic processes. We encourage the submission of manuscripts (original data and reviews) dealing with all aspects of cellular pathology, including those related to mechanisms of genetic, infectious, or acquired diseases, autoimmune disorders, ageing, and cellular damage through extrinsic causes. We especially welcome submissions that provide novel insights and/or conceptual advances to the knowledge of various aspects of cellular pathology in human diseases.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Cardiac Fibrosis: From Pathogenesis to Targeted Therapies (Deadline: 15 October 2023)
- Molecular and Cellular Mechanisms of Neuro-Cardiac Interactions (Deadline: 15 October 2023)
- Oxidative Stress and Antioxidant Strategies: Relationships and Cellular Pathways for Human Health (Deadline: 15 October 2023)
- Molecular and Cellular Regulation of the Skeletal System in Healthy and Pathological Conditions II (Deadline: 15 October 2023)
- Regulation of Blood-Brain Barrier in Health and Disease (Deadline: 17 October 2023)
- Non-coding RNA in Carcinogenesis (Deadline: 20 October 2023)
- Diabetic Retinopathy: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 25 October 2023)
- Molecular and Cellular Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) (Deadline: 27 October 2023)
- Obesity Pathogenesis: Insights from Molecular and Cellular Biology (Deadline: 31 October 2023)
- Understanding Retinopathy at the Neuro-Glial-Vascular Intersection: Mechanisms, and Potential Therapeutic Targets (Deadline: 31 October 2023)
- Advances in Diabetes Pathophysiology and Treatment (Deadline: 31 October 2023)
- Cellular and Molecular Mechanisms of Lysosomal Storage Disorders (Deadline: 31 October 2023)
- Oral Cancer: From Cellular and Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 October 2023)
- Cellular Mechanisms Associated with Intermittent Hypoxia (Deadline: 31 October 2023)
- Onco-Cardiologic Aspects of Chronic Heart Failure: Novel Molecular Mechanisms and Pharmacologic Treatment Options (Deadline: 31 October 2023)
- Involvement of Inflammation in Pathogenesis of Arterial and Venous Thromboembolic Disease (Deadline: 1 November 2023)
- Intracellular Mechanism in Differentiation, Proliferation and Cell Death (Deadline: 1 November 2023)
- Cellular and Molecular Alterations in the Down Syndrome Brain: A Starting Point for the Design of Therapeutic Approaches (Deadline: 15 November 2023)
- The Inflammation in Acute and Chronic Liver Injury (Deadline: 15 November 2023)
- Sepsis: Genetics, Pathogenesis, Diagnostics and Therapeutics (Deadline: 15 November 2023)
- Skeletal Muscle Atrophy in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 15 November 2023)
- Vascular Growth Factors in Health and Diseases (Deadline: 15 November 2023)
- Ubiquitin and Ubiquitin-Like Proteins: From Molecular Mechanisms to Human Diseases (Deadline: 15 November 2023)
- Oral Microbiome in Oral and Systemic Disease: Association or Causation? (Deadline: 23 November 2023)
- New Advances in Molecular Mechanisms of Chronic Kidney Disease (Deadline: 30 November 2023)
- Molecular Pathogenesis of PH: Group 1 and Beyond (Deadline: 30 November 2023)
- Recent Advances in the Field of Metastatic Melanoma (Deadline: 30 November 2023)
- Tuberculosis: From Pathogenesis to Targeted Therapies (Deadline: 30 November 2023)
- Neuroprotection in Ischemic Stroke: From Mechanisms to Therapeutics (Deadline: 30 November 2023)
- Role and Importance of Tumor Suppressor Genes in Cancer (Deadline: 30 November 2023)
- Metastatic Castration-Resistant Prostate Cancer: Molecular Mechanisms and Novel Treatment Strategies (Deadline: 30 November 2023)
- Cell-Penetrating Peptides (CPPs) in Cancer: From Molecular Mechanisms to Applications in Diagnostic and Therapeutic Opportunities (Deadline: 30 November 2023)
- Focus on Machinery of Cell Death (Deadline: 30 November 2023)
- Reactive Oxygen Species and Oxidative Stress in Cellular Homeostasis and Pathophysiology (Deadline: 30 November 2023)
- Viruses and Cancer: From Cellular Mechanism to Therapeutic Aspects (Deadline: 1 December 2023)
- Cellular and Molecular Basis of Wound Healing II (Deadline: 1 December 2023)
- Mitochondria in Cancer: A Neglected Functional Reprogramming with Fundamental Pathophysiological Implications II (Deadline: 1 December 2023)
- Melanoma: From Molecular Mechanisms to Therapeutic Opportunities—Series 2 (Deadline: 15 December 2023)
- State of the Art in Idiopathic Pulmonary Fibrosis-Series 2 (Deadline: 15 December 2023)
- Molecular and Cellular Mechanisms of Chronic Pain (Deadline: 15 December 2023)
- The Role of Intestinal Epithelial Cells in Health and Disease (Deadline: 15 December 2023)
- Molecular Pathways in Medicine and Cell Models of Disease (Deadline: 15 December 2023)
- Cellular and Molecular Mechanisms of Action of Drugs and Nutraceuticals of Marine Origin (Deadline: 20 December 2023)
- Drosophila Models of Development and Disease (Deadline: 20 December 2023)
- Molecular Mechanisms of Atherosclerosis and Vascular Senescence (Deadline: 20 December 2023)
- Novel Insights into Molecular Mechanisms of Renal Fibrosis (Deadline: 25 December 2023)
- From Pathology to Therapeutics: The Long Journey in Cardio-Renal Diseases (Deadline: 31 December 2023)
- Molecular Mechanisms and Clinical Treatments of Neurofibromatosis Type 1 Related Tumors (Deadline: 31 December 2023)
- Tumor Immune Microenvironment for Effective Therapy II (Deadline: 31 December 2023)
- Advances in Cellular and Molecular Research in Breast Cancer (Deadline: 31 December 2023)
- Pulmonary Hypertension - Cellular and Molecular Changes in the Lung and in the Right Ventricle (Deadline: 31 December 2023)
- Rickettsial Diseases: From Pathogenesis to Targeted Therapies (Deadline: 31 December 2023)
- Spotlight on Neuromuscular Diseases: Pathomechanisms and New Therapeutic Targets (Deadline: 31 December 2023)
- Cellular and Molecular Mechanisms of Bone Diseases (Deadline: 31 December 2023)
- Changes in Thyrocytes during Thyroid Disease and Thyroid Cancer (Deadline: 31 December 2023)
- Hypoxia and Cancer: New Aspects 2.0 (Deadline: 31 December 2023)
- Cellular and Molecular Mechanisms Underlying Large-Vessel Vasculitis (Deadline: 31 December 2023)
- Cell Biology Research in Germany: State-of-the-Art and Perspectives in Cellular Pathology (Deadline: 31 December 2023)
- Protein Misfolding Diseases: From Experimental Approaches to Therapeutic Opportunities (Deadline: 31 December 2023)
- Extracellular Vesicles and Nucleic Acids in Health and Disease (Deadline: 31 December 2023)
- Cellular and Molecular Mechanism of Motor Neuron Diseases (Deadline: 31 December 2023)
- New Discoveries in Dermatopathology: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 December 2023)
- Molecular Basis of Multiple Sclerosis Development and Treatment (Deadline: 31 December 2023)
- Recent Advances in Interstitial Lung Diseases (Deadline: 31 December 2023)
- Coagulation Disorders: Molecular Mechanisms and Novel Treatment Strategies (Deadline: 15 January 2024)
- Cellular and Clinical Mechanisms of Obesity and Diabetes and Their Complications (Deadline: 15 January 2024)
- Cellular and Molecular Mechanisms of Organ Fibrosis (Deadline: 15 January 2024)
- Molecular Mechanisms of Platelet Adhesion and Activation (Deadline: 15 January 2024)
- Cellular Reprogramming during Sepsis and Potential Therapeutic Targets (Deadline: 15 January 2024)
- New Advances in Pancreatic Cancer (Deadline: 20 January 2024)
- Identifying Molecular or Cellular Level Pathomechanisms for Possible Therapeutic/Neuroprotective Interventions in Traumatic Brain Injury (Deadline: 31 January 2024)
- Emerging Research in Renal Cell Carcinoma (Deadline: 31 January 2024)
- Amyotrophic Lateral Sclerosis: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 January 2024)
- Nonalcoholic Steatohepatitis (NASH): From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 January 2024)
- Oral Diseases: Biological and Molecular Pathogenesis (Deadline: 31 January 2024)
- Leukemia: Cellular Mechanism and Therapeutic Potential (Deadline: 31 January 2024)
- Hepatology: From Natural History to Therapeutics—Second Edition (Deadline: 31 January 2024)
- Molecular and Cellular Mechanisms of Cancers: Prostate Cancer (Deadline: 31 January 2024)
- Molecular and Cellular Mechanisms of Lymphomas (Deadline: 1 February 2024)
- Human Placenta and Trophoblast Cells in Pregnancy Development (Deadline: 5 February 2024)
- Antiphospholipid Syndrome: Molecular Mechanisms and Novel Therapies (Deadline: 10 February 2024)
- Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States (Deadline: 15 February 2024)
- Extracellular Vesicles in Health and Disease 2023 (Deadline: 15 February 2024)
- Novel Insights into Molecular Mechanisms and Therapy of Asthma (Deadline: 15 February 2024)
- Emerging Therapeutic Approaches for Chronic Liver Diseases (Deadline: 15 February 2024)
- Galectins in Health and Disease (Deadline: 15 February 2024)
- Cardiovascular Immunopathology (Deadline: 15 February 2024)
- Molecular Advances and New Therapeutic Approaches in Endometriosis (Deadline: 20 February 2024)
- Cellular Glycosphingolipids in Cancer (Deadline: 25 February 2024)
- Advances in Leukocyte Migration and Location in Health and Disease (Deadline: 29 February 2024)
- Impact of Platelet Defects on Pathophysiological Processes II (Deadline: 29 February 2024)
- Molecular Mechanism of Muscle Formation, Muscle Homeostasis, and Muscle Wasting (Deadline: 29 February 2024)
- New Insights into Pathogenesis and Novel Therapeutic Approaches in Systemic Lupus Erythematosus (Deadline: 29 February 2024)
- Podocyte Pathophysiology (Deadline: 29 February 2024)
- Head and Neck Cancer: From Mechanisms to Therapeutics (Deadline: 29 February 2024)
- Rare Monogenic Diseases: Molecular Mechanism and Novel Therapies (Deadline: 15 March 2024)
- Brain Tumors: from Neuropathology to Molecular Biology (Deadline: 20 March 2024)
- Pathogenesis of Prion Diseases (Deadline: 31 March 2024)
- Cardiac and Neuromuscular Channelopathies: Cellular and Molecular Mechanisms (Deadline: 31 March 2024)
- Cancer-Related Signaling Cascades: Current Knowledge and Potential Therapeutic Targets (Deadline: 31 March 2024)
- Genetics and Pathomechanisms of Amyotrophic Lateral Sclerosis (ALS) (Deadline: 31 March 2024)
- Novel Advances in Cellular and Molecular Mechanisms Governing Liver Pathophysiology (Deadline: 31 March 2024)
- Apoptosis and Alternative Modes of Cell Death as Targets for Anticancer Therapy (Deadline: 30 April 2024)
- Pathophysiological Mechanisms of Cholestatic and Metabolic-Associated Fatty Liver Disease (Deadline: 31 May 2024)
- Recent Advances in the Development and Progression of Kidney Diseases (Volume II) (Deadline: 31 July 2024)
- Pathophysiology of Signal Transduction in Cardiovascular and Pulmonary Disease II (Deadline: 1 August 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Cardiomyocytes, Myocardial Hypertrophy, and Heart Failure
- Cellular and Molecular Pathophysiology of Vascular Proliferative Diseases
- Cystic Fibrosis: Cells, Physiopathology and Emerging Therapies
- Epigenetics in Myeloproliferative Neoplasms and Acute Myeloid Leukemia
- Feature Papers in ‘Cellular Pathology’
- Molecular and Cellular Mechanisms of Cancers: Colorectal Cancer
- Molecular Determinants of Skin Integrity
- Molecular Mechanisms and Current Treatment Strategy of Sarcopenia and Cachexia
- Multiple Myeloma and Cellular Therapies
- Novel Biomarkers for Alzheimer’s Disease and Other Neurodegenerative Diseases
- Recent Advances in Liver Repair Strategies
- The Research of Biomarkers in Colorectal Cancer and Gastric Cancer
